Tofacitinib Therapy, the Lender of Last Resort

J Crohns Colitis. 2021 Apr 6;15(4):694. doi: 10.1093/ecco-jcc/jjaa198.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Anti-Inflammatory Agents / therapeutic use
  • Colitis, Ulcerative / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Induction Chemotherapy
  • Maintenance Chemotherapy
  • Methylprednisolone / therapeutic use
  • Piperidines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • tofacitinib
  • Methylprednisolone